Effects of norcantharidin, a protein phosphatase type-2A inhibitor, on the growth of normal and malignant haemopoietic cells
- 1 June 1995
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 31 (6) , 953-963
- https://doi.org/10.1016/0959-8049(95)00050-x
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Oscillation of MPF is accompanied by periodic association between cdc25 and cdc2-cyclin BCell, 1992
- Inhibitory effect of norcantharidin on K562 human myeloid leukemia cells in vitroLeukemia Research, 1991
- Distinct, essential roles of type 1 and 2A protein phosphatases in the control of the fission yeast cell division cycleCell, 1990
- Driving the cell cycle: M phase kinase, its partners, and substratesCell, 1990
- In vitro disassembly of the nuclear lamina and M phase-specific phosphorylation of lamins by cdc2 kinaseCell, 1990
- Okadaic acid: a new probe for the study of cellular regulationTrends in Biochemical Sciences, 1990
- Identification of major nucleolar proteins as candidate mitotic substrates of cdc2 kinaseCell, 1990
- A putative protein kinase overcomes pheromone-induced arrest of cell cycling in S. cerevisiaeCell, 1989
- Purification of MPF from starfish: Identification as the H1 histone kinase p34cdc2 and a possible mechanism for its periodic activationCell, 1989
- Cantharidin poisoning associated with specific binding site in liverBiochemical and Biophysical Research Communications, 1987